{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:10Z","timestamp":1790743870796,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["Z01 ES101074"],"award-info":[{"award-number":["Z01 ES101074"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Environmental exposures have been associated with the juvenile idiopathic inflammatory myopathies (JIIM). We undertook a questionnaire-based study to evaluate patient-reported exposures as possible risk factors for JIIM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Findings<\/jats:title>\n                <jats:p>One-hundred-seven patients with JIIM were enrolled in a myositis natural history protocol and completed environmental questionnaires. Frequencies of exposures in clinical and myositis-specific autoantibody (MSA) groups were examined. Patients with juvenile dermatomyositis (JDM) and juvenile connective tissue myositis (JCTM) more frequently received an immunization within 1 year of diagnosis compared to juvenile polymyositis (57.5 and 71.4% vs 0.0%, <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.017). JCTM patients were more often underweight at diagnosis relative to JDM patients (42.9% vs 7.0%, <jats:italic>p<\/jats:italic>\u2009=\u20090.002). MSA-negative patients more frequently had gastroenteritis within a year of diagnosis compared to patients with anti-MDA5 autoantibodies (28.6% vs 0.0%, <jats:italic>p<\/jats:italic>\u2009=\u20090.032). Heavy exercise was more frequent in MSA-negative and anti-MDA5 groups compared to the anti-TIF-1 autoantibody group (42.9 and 35.3% vs. 9.0%, <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.047). Medications received within 1 year of diagnosis were more frequent in MSA-negative patients relative to those with anti-MDA5 autoantibodies (92.9% vs. 52.8% <jats:italic>p<\/jats:italic>\u2009=\u20090.045). Being breastfed &gt;\u20096\u2009months was more frequent in MSA-negative patients (88.9%) compared to anti-TIF-1 and anti-MDA5 autoantibody groups (41.2 and 28.6%, <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.036).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Certain environmental exposures prior to diagnosis differed among clinical and serologic subgroups of JIIM, suggesting additional exposures to be explored as possible risk factors for JIIM phenotypes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00684-9","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T11:04:19Z","timestamp":1649761459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes"],"prefix":"10.1186","volume":"20","author":[{"given":"Jonathan C.","family":"Scalabrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam I.","family":"Schiffenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam Noroozi","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Volochayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira N.","family":"Targoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-2458","authenticated-orcid":false,"given":"Lisa G.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"684_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2017.12.053","volume":"195","author":"LM Pachman","year":"2018","unstructured":"Pachman LM, Khojah AM. Advances in juvenile Dermatomyositis: myositis specific antibodies aid in understanding disease heterogeneity. J Pediatr. 2018;195:16\u201327.","journal-title":"J Pediatr"},{"issue":"4","key":"684_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, et al. Childhood myositis heterogeneity collaborative study group. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(4):223\u201343.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"684_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, et al. With the childhood myositis heterogeneity collaborative study group. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(1):25\u201341.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"684_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.pcl.2018.04.006","volume":"65","author":"AM Huber","year":"2018","unstructured":"Huber AM. Juvenile idiopathic inflammatory myopathies. Pediatr Clin N Am. 2018;65(4):739\u201356.","journal-title":"Pediatr Clin N Am"},{"issue":"5","key":"684_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","volume":"14","author":"FW Miller","year":"2018","unstructured":"Miller FW, Lamb JA, Schmidt J, Nagaraju K. Risk factors and disease mechanisms in myositis. Nat Rev Rheumatol. 2018;14(5):255\u201368.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"684_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","volume":"47","author":"C Manlhiot","year":"2008","unstructured":"Manlhiot C, Liang L, Tran D, Bitnun A, Tyrrell PN, Feldman BM. Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. Rheumatology (Oxford). 2008;47(4):526\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"684_CR7","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/rheumatology\/keq277","volume":"49","author":"LG Rider","year":"2010","unstructured":"Rider LG, Wu L, Mamyrova G, Targoff IN, Miller FW. Childhood myositis heterogeneity collaborative study group. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2010;49(12):2381\u201390.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"684_CR8","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/art.1780400822","volume":"40","author":"LM Pachman","year":"1997","unstructured":"Pachman LM, Hayford JR, Hochberg MC, Pallansch MA, Chung A, Daugherty CD, et al. New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40(8):1526\u201333.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"684_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/art.21068","volume":"53","author":"LM Pachman","year":"2005","unstructured":"Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases research registry. Arthritis Rheum. 2005;53(2):166\u201372.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"684_CR10","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/art.37985","volume":"65","author":"M Shah","year":"2013","unstructured":"Shah M, Targoff IN, Rice MM, Miller FW, Rider LG. Childhood myositis heterogeneity collaborative study group. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 2013;65(7):1934\u201341.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"684_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/acr.22358","volume":"66","author":"MA Orione","year":"2014","unstructured":"Orione MA, Silva CA, Sallum AM, Campos LM, Omori CH, Braga AL, et al. Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy. Arthritis Care Res (Hoboken). 2014;66(10):1571\u20135.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"684_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis. Parts 1 and 2. N Engl J Med. 1975;292:403\u20137.","journal-title":"N Engl J Med"},{"issue":"3","key":"684_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11926-996-0025-3","volume":"8","author":"IN Targoff","year":"2006","unstructured":"Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep. 2006;8(3):196\u2013203.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"684_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/BOR.0b013e32832a2e16","volume":"21","author":"KP Liao","year":"2009","unstructured":"Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol. 2009;21(3):279\u201383.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"684_CR15","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/1529-0131(199810)41:10<1714::AID-ART3>3.0.CO;2-U","volume":"41","author":"GS Cooper","year":"1998","unstructured":"Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998;41(10):1714\u201324.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"684_CR16","first-page":"1218","volume":"16","author":"MG Lyon","year":"1989","unstructured":"Lyon MG, Bloch DA, Hollak B, Fries JF. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol. 1989;16(9):1218\u201324.","journal-title":"J Rheumatol"},{"key":"684_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2474-15-67","volume":"15","author":"L Gan","year":"2014","unstructured":"Gan L, O'Hanlon TP, Gordon AS, Rider LG, Miller FW, Burbelo PD. Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis. BMC Musculoskelet Disord. 2014;15:67.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9631","key":"684_CR18","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371(9631):2201\u201312.","journal-title":"Lancet."},{"issue":"6","key":"684_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/oxfordjournals.aje.a112341","volume":"104","author":"MJ Koch","year":"1976","unstructured":"Koch MJ, Brody JA, Gillespie MM. Childhood polymyositis: a case-control study. Am J Epidemiol. 1976;104(6):627\u201331.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"684_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/art.1780180410","volume":"18","author":"M Koch","year":"1975","unstructured":"Koch M, Brody JA, Nemo GJ, Sever JL. Antibody levels to parainfluenza, rubella, measles, and influenza a virus in children with polymyositis. Arthritis Rheum. 1975;18(4):353\u20135.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"684_CR21","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C, et al. UK juvenile Dermatomyositis research group. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther. 2014;16(4):R138.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"684_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.autrev.2007.11.007","volume":"7","author":"L Stojanovich","year":"2008","unstructured":"Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmun Rev. 2008;7(3):209\u201313.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"684_CR23","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","volume":"56","author":"G Mamyrova","year":"2017","unstructured":"Mamyrova G, Rider LG, Ehrlich A, Jones O, Pachman LM, Nickeson R, et al. Environmental factors associated with disease flare in juvenile and adult dermatomyositis. Rheumatology (Oxford). 2017;56(8):1342\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"684_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpeds.2020.06.046","volume":"226","author":"TB Rubinstein","year":"2020","unstructured":"Rubinstein TB, Bullock DR, Ardalan K, Mowrey WB, Brown NM, Bauman LJ, et al. Adverse childhood experiences are associated with childhood-onset arthritis in a National Sample of US youth: an analysis of the 2016 National Survey of Children's health. J Pediatr. 2020;226:243\u2013250.e2.","journal-title":"J Pediatr"},{"issue":"42","key":"684_CR25","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1016\/j.vaccine.2017.08.018","volume":"35","author":"NL Bragazzi","year":"2017","unstructured":"Bragazzi NL, Watad A, Amital H, Shoenfeld Y. Debate on vaccines and autoimmunity: do not attack the author, yet discuss it methodologically. Vaccine. 2017;35(42):5522\u20136.","journal-title":"Vaccine."},{"key":"684_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2019.03.007","volume":"203","author":"A Watad","year":"2019","unstructured":"Watad A, Bragazzi NL, McGonagle D, Adawi M, Bridgewood C, Damiani G, et al. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases. Clin Immunol. 2019;203:1\u20138.","journal-title":"Clin Immunol"},{"issue":"7","key":"684_CR27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/pds.1354","volume":"16","author":"O Yu","year":"2007","unstructured":"Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, et al. Hepatitis B vaccine and risk of autoimmune thyroid disease: a vaccine safety Datalink study. Pharmacoepidemiol Drug Saf. 2007;16(7):736\u201345.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"684_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.autrev.2013.08.005","volume":"13","author":"JP St\u00fcbgen","year":"2014","unstructured":"St\u00fcbgen JP. A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev. 2014;13(1):31\u20139.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"684_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.semarthrit.2017.05.011","volume":"47","author":"SK Tedeschi","year":"2017","unstructured":"Tedeschi SK, Barbhaiya M, Malspeis S, Lu B, Sparks JA, Karlson EW, et al. Obesity and the risk of systemic lupus erythematosus among women in the Nurses' health studies. Semin Arthritis Rheum. 2017;47(3):376\u201383.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"684_CR30","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1136\/annrheumdis-2014-205459","volume":"73","author":"B Lu","year":"2014","unstructured":"Lu B, Hiraki LT, Sparks JA, Malspeis S, Chen CY, Awosogba JA, et al. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Ann Rheum Dis. 2014;73(11):1914\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"684_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/ard.2006.061846","volume":"66","author":"KA Young","year":"2007","unstructured":"Young KA, Parrish LA, Zerbe GO, Rewers M, Deane KD, Michael Holers V, et al. Perinatal and early childhood risk factors associated with rheumatoid factor positivity in a healthy paediatric population. Ann Rheum Dis. 2007;66(2):179\u201383.","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 1","key":"684_CR32","first-page":"S114","volume":"65","author":"DB Buller","year":"2011","unstructured":"Buller DB, Cokkinides V, Hall HI, Hartman AM, Saraiya M, Miller E, et al. Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. J Am Acad Dermatol. 2011;65(5 Suppl 1):S114\u201323.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"684_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1590\/S0034-89102004000200016","volume":"38","author":"LR Kroeff","year":"2004","unstructured":"Kroeff LR, Mengue SS, Schmidt MI, Duncan BB, Favaretto AL, Nucci LB. Fatores associados ao fumo em gestantes avaliadas em cidades brasileiras [correlates of smoking in pregnant women in six Brazilian cities]. Rev Saude Publica. 2004;38(2):261\u20137 Portuguese.","journal-title":"Rev Saude Publica"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00684-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T11:18:55Z","timestamp":1649762335000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00684-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00684-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In compliance with the Helsinki Declaration, the study was approved by Institutional Review Board of the NIEHS as part of the 94E-0165 Myositis Natural History Study and 03E-099 Twins and Siblings Discordant for Systemic Rheumatic Diseases protocols. Written and informed assent or consent was obtained from patients and, when applicable, the parents of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Included in research study consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}